Skip to main content
. 2022 May 31;12:909035. doi: 10.3389/fonc.2022.909035

Figure 3.

Figure 3

The Kaplan-Meier curves of (A) progression-free survival (PFS) and (B) overall survival (OS) of unresectable or metastatic hepatocellular carcinoma patients in the efficacy-evaluable population.